(redirected from Cell motility)
Also found in: Dictionary, Medical, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for motility

References in periodicals archive ?
Further tests showed the compound works by limiting the cells' ability to contract, a critical function for cell motility.
P38, ERK is an important signal transducer that is responsible for proliferation, differentiation and ECM-dependent cell motility (Zhong et al.
MTOR is a serine/threonine protein kinase which regulates cell growth, cell proliferation, cell motility, cell survival, protein synthesis, and transcription.
Liotta suggests that AMF works by changing the chemical composition of a molecule on cell membranes; this change may increase cell motility by making the membrane more fluid.
The biology of metastasis is driven by molecular changes within cancer cells that enable cell motility, which contributes to the spread of cancer throughout the body.
London, Mar 19 (ANI): Scientists have discovered that members of an enzyme family found in humans and throughout the plant and animal kingdoms play a crucial role in regulating cell motility.
The 12 articles in the 2005 edition of this annual series review the biochemical and biomechanical bases of cell motility, chlorine metabolites as markers for detection of malignant cancer and as therapeutic response indicators, and the state of the art in retinal prostheses.
Soil, who specializes in cell motility research, says new technology could reduce odors while expanding hog manure nutrient value when used for fertilizer.
pl9Arf-p53 Tumor suppressor pathway regulates cell motility by suppression of phosphoinositide 3-kinase and Racl GTPase activities.
ADFs help the cell to recycle actin, a protein which controls critical functions such as cell motility, muscle contraction, and cell division and signaling," Dr Baum said.
Summary: TEHRAN (FNA)- Researchers discovered that the natural compound sceptrin, which is found in marine sponges, reduces cancer cell motility (movement) and has very low toxicity.
They also consider potential applications of research findings to clinical problems, particularly cell motility in cancer.
But the exact processes involved are still part of what Taylor calls "the black box" of cell motility and the subject of intensive study.
Its pharmacological profile from preclinical studies based on in vitro, cell-based and animal xenograft studies suggests that MTKi-327 inhibits directly tumor growth as well as prevents tumor invasion and metastases by interfering with cancer cell motility and tumor-associated lymphangiogenesis.
Researchers also discovered that Procellera technology increased keratinocyte mitochondrial membrane potential, essentially "energizing" the mitochondria through its electrical fields to improve its cell motility capacity, due to its ability to "communicate" with keratinocytes via redox-dependent processes improving keratinocyte migration.